ArticleOncoTargets and therapy2021

Lipid-Polymer Hybrid Nanoparticle-Based Combination Treatment with Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma.

Dehui Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.